According to the latest status from November 2024, Gan & Lee Pharmaceuticals paid a total of 0 CNY per share in dividends within the last 12 months. With the current Gan & Lee Pharmaceuticals price of 47.92 CNY, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.
| 0.63 % Dividend Yield | = |
|
A dividend is paid times per year. Last year, the payout months were and .
| Paydate | Dividend |
|---|---|
| 7/18/2024 | 0.2 |
| 7/20/2022 | 0.3 |
| 6/21/2021 | 0.4 |
| 9/20/2020 | 0.36 |
3 years
5 years
10 years
25 Years
Max
The dividend per year chart for Gan & Lee Pharmaceuticals provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.
A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Gan & Lee Pharmaceuticals’s potential for long-term investment and income generation through dividends.
Incorporate the dividend data in evaluating Gan & Lee Pharmaceuticals's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.
| Date | Gan & Lee Pharmaceuticals Dividend |
|---|---|
| 2022 | 0.3 undefined |
| 2021 | 0.4 undefined |
| 2020 | 0.36 undefined |
| Dividend | Dividend (Estimate) | |
|---|---|---|
| 2017 | 0 CNY | 0 CNY |
| 2018 | 0 CNY | 0 CNY |
| 2019 | 0 CNY | 0 CNY |
| 2020 | 0.36 CNY | 0 CNY |
| 2021 | 0.4 CNY | 0 CNY |
| 2022 | 0.3 CNY | 0 CNY |
| 2023 | 0 CNY | 0 CNY |
| 2024e | 0 CNY | 0 CNY |
| 2025e | 0 CNY | 0 CNY |
| 2026e | 0 CNY | 0 CNY |
Gan & Lee Pharmaceuticals has been increasing the dividend for 1 years.
Over the past 7 years, Gan & Lee Pharmaceuticals has increased it by an annual 0 %.
Over a five-year period, the distribution increased by 0%.
Analysts expect a Dividend Cut of -100% for the current fiscal year.
3 years
5 years
10 years
25 Years
Max
The yearly payout ratio for Gan & Lee Pharmaceuticals represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.
A lower payout ratio for Gan & Lee Pharmaceuticals could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.
Evaluate Gan & Lee Pharmaceuticals's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.
| Date | Gan & Lee Pharmaceuticals Payout ratio |
|---|---|
| 2026e | 15.46 % |
| 2025e | 15.46 % |
| 2024e | 15.46 % |
| 2023 | 15.46 % |
| 2022 | -38.33 % |
| 2021 | 15.46 % |
| 2020 | 15.46 % |
| 2019 | 15.46 % |
| 2018 | 15.46 % |
| 2017 | 15.46 % |
| Payout ratio | |
|---|---|
| 2017 | 15.46 % |
| 2018 | 15.46 % |
| 2019 | 15.46 % |
| 2020 | 15.46 % |
| 2021 | 15.46 % |
| 2022 | -38.33 % |
| 2023 | 15.46 % |
| 2024e | 15.46 % |
| 2025e | 15.46 % |
| 2026e | 15.46 % |
Gan & Lee Pharmaceuticals’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.
Examining Gan & Lee Pharmaceuticals's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.
Gan & Lee Pharmaceuticals's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.
Changes in Gan & Lee Pharmaceuticals’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.
Over the past 12 months, Gan & Lee Pharmaceuticals paid a dividend of 0.3 CNY . This corresponds to a dividend yield of about 0.63 %. For the coming 12 months, Gan & Lee Pharmaceuticals is expected to pay a dividend of 0 CNY.
The current dividend yield of Gan & Lee Pharmaceuticals is 0.63 %.
Gan & Lee Pharmaceuticals pays a quarterly dividend. This is distributed in the months of September, June, July, July.
Gan & Lee Pharmaceuticals paid dividends every year for the past 3 years.
For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.
Gan & Lee Pharmaceuticals is assigned to the 'Health' sector.
To receive the latest dividend of Gan & Lee Pharmaceuticals from 6/18/2024 amounting to 0.2 CNY, you needed to have the stock in your portfolio before the ex-date on 6/18/2024.
The last dividend was paid out on 6/18/2024.
In the year 2023, Gan & Lee Pharmaceuticals distributed 0.3 CNY as dividends.
The dividends of Gan & Lee Pharmaceuticals are distributed in CNY.
Our stock analysis for Gan & Lee Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Gan & Lee Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.